```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[S. 2879 Introduced in Senate (IS)]

106th CONGRESS
  2d Session
                                S. 2879

   To amend the Public Health Service Act to establish programs and 
  activities to address diabetes in children and youth, and for other 
                               purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             July 17, 2000

Ms. Collins (for herself, Mr. Breaux, Mr. Abraham, Mr. Bunning, and Mr. 
Craig) introduced the following bill; which was read twice and referred 
       to the Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL

 
   To amend the Public Health Service Act to establish programs and 
  activities to address diabetes in children and youth, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Pediatric Diabetes Research and 
Prevention Act''.

SEC. 2. PROGRAMS OF CENTERS FOR DISEASE CONTROL AND PREVENTION.

    Part B of title III of the Public Health Service Act (42 U.S.C. 243 
et seq.) is amended by inserting after section 317G the following 
section:

``SEC. 317H. DIABETES IN CHILDREN AND YOUTH.

    ``(a) National Registry on Juvenile Diabetes.--The Secretary, 
acting through the Director of the Centers for Disease Control and 
Prevention, shall develop a system to collect data on type 1 diabetes 
(or juvenile diabetes), including information with respect to incidence 
and prevalence, and shall establish a national registry for such data.
    ``(b) Advisory Committee on the National Registry on Juvenile 
Diabetes.--
            ``(1) Establishment.--There is established a committee to 
        be known as the Advisory Committee on the National Registry on 
        Juvenile Diabetes (referred to in this subsection as the 
        `committee').
            ``(2) Membership.--The committee shall be composed of at 
        least one member, to be appointed by the Secretary, acting 
        through the Director of the Centers for Disease Control and 
        Prevention, representing each of the following:
                    ``(A) Epidemiologists with experience in data 
                registries.
                    ``(B) Patients with type 1 diabetes (or juvenile 
                diabetes), or family members of the patients.
                    ``(C) Representatives from nonprofit organizations 
                focused on diabetes research.
                    ``(D) Clinicians who have worked with data 
                registries.
                    ``(E) Statisticians.
                    ``(F) Ethicists.
                    ``(G) Attorneys.
                    ``(H) Other individuals with an interest in 
                developing and maintaining the registry described in 
                subsection (a).
            ``(3) Period of appointment; vacancies.--Members shall be 
        appointed for the life of the committee. Any vacancy in the 
        committee shall not affect the powers of the committee, but 
        shall be filled in the same manner as the original appointment.
            ``(4) Duties.--The committee shall study, and make 
        recommendations to the Secretary regarding, the development and 
        maintenance of the registry described in subsection (a).
            ``(5) Powers.--
                    ``(A) Hearings.--The committee may hold such 
                hearings, sit and act at such times and places, take 
                such testimony, and receive such evidence as the 
                committee considers advisable to carry out the 
                objectives of this section.
                    ``(B) Information from federal agencies.--The 
                committee may secure directly from any Federal 
                department or agency such information as the committee 
                considers necessary to carry out the provisions of this 
                section. Upon request of the committee, the head of 
                such department or agency shall furnish such 
                information to the committee.
                    ``(C) Postal services.--The committee may use the 
                United States mails in the same manner and under the 
                same conditions as other departments and agencies of 
                the Federal Government.
            ``(6) Personnel.--
                    ``(A) Travel expenses.--The members of the 
                committee shall not receive compensation for the 
                performance of services for the committee, but shall be 
                allowed travel expenses, including per diem in lieu of 
                subsistence, at rates authorized for employees of 
                agencies under subchapter I of chapter 57 of title 5, 
                United States Code, while away from their homes or 
                regular places of business in the performance of 
                services for the committee. Notwithstanding section 
                1342 of title 31, United States Code, the Secretary may 
                accept the voluntary and uncompensated services of 
                members of the committee.
                    ``(B) Detail of government employees.--Any Federal 
                Government employee may be detailed to the committee 
                without reimbursement, and such detail shall be without 
                interruption or loss of civil service status or 
                privilege.
            ``(7) Permanent committee.--Section 14 of the Federal 
        Advisory Committee Act (5 U.S.C. App.) shall not apply to the 
        committee.
    ``(c) Type 2 Diabetes in Youth.--The Secretary, acting through the 
Director of the Centers for Disease Control and Prevention and in 
consultation with the Administrator of the Health Resources and 
Services Administration, shall implement a national public health 
effort to address type 2 diabetes in youth, including--
            ``(1) enhancing surveillance systems and expanding research 
        to better assess the prevalence of type 2 diabetes in youth and 
        determine the extent to which type 2 diabetes is incorrectly 
        diagnosed as type 1 diabetes (or juvenile diabetes) among 
        children;
            ``(2) assisting States in establishing coordinated school 
        health programs and physical activity and nutrition 
        demonstration programs to control weight and increase physical 
        activity among youth; and
            ``(3) developing and improving laboratory methods to assist 
        in diagnosis, treatment, and prevention of diabetes including 
        developing noninvasive ways to monitor blood glucose to prevent 
        hypoglycema and improving glucometers that measure blood 
        glucose.
    ``(d) Authorization of Appropriations.--There are authorized to be 
appropriated to carry out this section such sums as may be necessary 
for each of fiscal years 2001 through 2005.''.

SEC. 3. PROGRAMS OF NATIONAL INSTITUTES OF HEALTH.

    Subpart 3 of part C of title IV of the Public Health Service Act 
(42 U.S.C. 285c et seq.) is amended by inserting after section 434 the 
following section:

``SEC. 434A. JUVENILE DIABETES.

    ``(a) Long-Term Epidemiology Studies.--
            ``(1) In general.--The Director of the Institute shall 
        conduct or support long-term epidemiology studies in which 
        individuals with type 1 diabetes (or juvenile diabetes) are 
        followed for 10 years or more. Such studies shall, in order to 
        provide a valuable resource for the purposes specified in 
        paragraph (2), provide for complete characterization of disease 
        manifestations, description of the appropriate medical history, 
        elucidation of environmental factors, delineation of 
        complications, description of results of usual medical 
        treatment, and acquisition of a variety of other potentially 
        valuable information and samples (such as samples of blood).
            ``(2) Purposes.--The purposes referred to in paragraph (1) 
        with respect to type 1 diabetes (or juvenile diabetes) are the 
        following:
                    ``(A) Delineation of potential environmental 
                triggers thought to precipitate or cause type 1 
                diabetes (or juvenile diabetes).
                    ``(B) Delineation of clinical characteristics or 
                lab measures associated with complications of the 
                disease.
                    ``(C) Specification of a potential study population 
                to enter into clinical trials for prevention and 
                treatment, as well as genetic studies.
    ``(b) Clinical Trial Infrastructure and Innovative Treatments for 
Juvenile Diabetes.--The Secretary, acting through the Director of the 
National Institutes of Health, shall support regional clinical centers 
for the cure of type 1 diabetes (or juvenile diabetes) and shall 
through such centers provide for--
            ``(1) a well-characterized population of children 
        appropriate for clinical trials;
            ``(2) well-trained clinical scientists able to conduct such 
        trials;
            ``(3) appropriate clinical settings able to house such 
        trials; and
            ``(4) appropriate statistical capability, data, safety, and 
        other monitoring capacity.
    ``(c) Development of Vaccine.--The Secretary, acting through the 
appropriate agencies of the Public Health Service, shall provide for a 
national effort to develop a vaccine for type 1 diabetes (or juvenile 
diabetes). Such effort shall provide for a combination of increased 
efforts in research and development of candidate vaccines, coupled with 
appropriate ability to conduct large clinical trials in children.
    ``(d) Authorization of Appropriations.--There are authorized to be 
appropriated to carry out this section such sums as may be necessary 
for each of fiscal years 2001 through 2005.''.
                                 <all>
```